![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/4/2020 09:35 | Don't forget all, there will still be several million placing shares getting washed through here.When they are cleared, this will soar again. | ![]() festario | |
16/4/2020 09:33 | I already did in the early 40s and I have already taken out my original stake. What I have left I am prepared to lose a large chunk of but obviously hope it will multibag. Doesn't mean I can't state an honest view or do you only like posts saying this will go to the moon? Managing risk then hoping for the best is what this game is about. | ![]() allstar4eva | |
16/4/2020 09:32 | Amazes me how much buying pressure it takes to move this back up.mm,s seem to take the share price where they want.Appols for the moaning but it is frustrating. | ![]() cambradjones | |
16/4/2020 09:31 | I worked on antibodies for my whole working life so I know a little bit about them. They are a much bigger protein than a cytokine and will be difficult to deliver via a nebuliser. Indeed my company was working on a nebulised form of an antibody but went for a Fab (which is just a part of an antibody and about a third of the size) to facilitate the delivery. TILS are going to struggle. | ![]() nobbygnome | |
16/4/2020 09:28 | Have you not learnt anything about share price movements in blue sky AIM stocks? | ![]() kop202 | |
16/4/2020 09:28 | Well don't invest and find another company that has a better chance of helping the fight against the virus | ![]() vitec | |
16/4/2020 09:26 | SNG no fda....as nt novel treatmen/ standard flu treatment. do some research reason for ncyt rise was going for fda :) | ![]() invester2010 | |
16/4/2020 09:26 | A good chance is just that- speculative! | ![]() allstar4eva | |
16/4/2020 09:25 | The share price drops and the drivel starts. Any simple research will show you that this has far more data to say that it has a very good chance of working. Suggest you do some research before posting rubbish | ![]() vitec | |
16/4/2020 09:23 | your better off, doing dd, and going for proper science that is being overlooked. if you think the guys on lse are experts in covid treatment.....then you have another thing coming. | ![]() invester2010 | |
16/4/2020 09:23 | Just managed to get my buy in here. Opening the gates now. | slinkyj | |
16/4/2020 09:22 | Investor2010 please don't pollute my thread. | ![]() nobbygnome | |
16/4/2020 09:21 | Yes so this is just like all the rest - speculative! That doesn't mean it won't come good or risk reward is not reasonable - it's a calculated risk just like the rest. | ![]() allstar4eva | |
16/4/2020 09:20 | The world is mad. The TILS product is further behind in the development process, will be more difficult to deliver and is less likely to work IMHO. | ![]() nobbygnome | |
16/4/2020 09:20 | droping.....hard. looks willl need to retest support at 40p....way over rated. they are using flu treatment to maybe takle covide - long shot. sold in the 70's oh the rampers on lse - disgusting | ![]() invester2010 | |
16/4/2020 09:20 | 230k buy at 64.62p...confident!! | ![]() likya123 | |
16/4/2020 09:19 | At the moment any company that has the slightest whiff of being to help in the fight against the virus is motoring only to fall back when punters realise that it was just momentum buying that took the share price to that level based on gossip and rumour. SNG is not in that catagory. It has an offering that could really make a difference. From a health stand point every government will want to save their citizens lives and every punter will want in. This is not an binary event but the trial results are the key. | ![]() vitec | |
16/4/2020 09:13 | Perhaps, it's just frustrating. Would be nice if we had an update RNS right now as to when we expect the urgent health study results. As those words imply news will come sooner than regular bio tech trials . This should be wiping the floor with the TILLS price right now. | slinkyj | |
16/4/2020 09:11 | This has a market cap 20mm less than tils. Buy no advice intended lol | ![]() d1nga | |
16/4/2020 09:10 | It is just profit taking. This has a habit of making higher highs so will expect some turnaround at some point in the near future. All of the data/research points to a postive outcome of the trial but there is no certainty if there was we would not be sitting at 60p plus the share price would be several pounds. Sit tight. | ![]() vitec | |
16/4/2020 09:10 | These are unprecedented times. Trials under normal circumstances obviously have to be allowed run their course. However, as far as I can gather, SNG's inhalation interferon beta treatment has already been proved to have few if any side affects in previous trials on copd and asthma patients, evidence from these and other anecdotal evidence shows it is highly likely that it will be effective as a treatment (not a cure) for the coronavirus . Waiting a few more weeks for more proof when thousands of people are dying everyday, and as each week passes increases the likelihood that the world is going into an ever deeper recession/depression from which could take many decades to recover seems madness to me. | ![]() acga | |
16/4/2020 09:09 | Just MM's shaking a few weaker holders out and collecting shares for the inevitable rise to come. | ![]() likya123 | |
16/4/2020 09:03 | This has to be undervalued at this stage surely?? I'm no expert but Tills price is very similar and not even at the advanced stage this is at. They are both developing / testing nebuliser inhaled drugs except SNG further ahead in trials with an RNS to boot. Any comments on this disparity greatly requested | slinkyj | |
16/4/2020 08:58 | I purchased a few of these a while ago. I also hold a few shares in other small, companies with similar interests, but having the benefit of several years of experience in this field and knowing just how many fail along the way only time will tell if one turns out a winner, meanwhile the only winners are company Directors :) | ![]() gbh2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions